Best Healthcare Market Research Companies in Colombia (2026 Guide)
An independent guide to the leading healthcare market research companies operating in Colombia for 2026. This guide profiles 5 firms across pharmaceutical research, INVIMA regulatory intelligence, EPS/PBS reimbursement studies, HEOR, and competitive intelligence — comparing capabilities and Colombia-specific expertise to help you select the right healthcare research partner in this pivotal Andean market.
Published 2026-06-11 · By BioNixus Research Team
5
Firms Profiled
$8B+
Pharma Market
INVIMA-Regulated
Market
8
FAQs Answered
Best Healthcare Market Research Companies in Colombia (2026)
The following healthcare market research companies have demonstrated operations or project delivery in Colombia as of 2026, covering pharmaceutical, regulatory, reimbursement, and health economics research:
- 1BioNixus — Best for: Colombia and South America healthcare research execution, INVIMA regulatory awareness, EPS/PBS market access intelligence, and Spanish-English bilingual delivery
- 2IQVIA Colombia — Best for: IMS pharma data, INVIMA regulatory analytics, real-world evidence, sales force effectiveness
- 3Ipsos Healthcare Colombia — Best for: large-scale quantitative and qualitative pharmaceutical research, physician and patient surveys
- 4Kantar Health (LATAM) — Best for: consumer health tracking, patient research, health and wellness insights across LATAM
- 5Euromonitor International — Best for: syndicated market sizing, Colombia country reports, consumer health category intelligence, five-year forecasts
Colombia Healthcare Market Research Landscape 2026
Colombia is one of the most important pharmaceutical markets in South America, valued at over $8 billion USD and growing steadily on the back of a population of 52 million, rising non-communicable disease burden, and a maturing multi-payer healthcare system anchored by the SGSSS (Sistema General de Seguridad Social en Salud). Colombia serves as a critical regional hub for Andean-region pharma strategies and multinational product launches.
INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) is Colombia's primary regulatory authority for pharmaceutical registration, clinical trials, and pharmacovigilance. The PBS (Plan de Beneficios en Salud) defines the reimbursable medicines list administered through EPS (Entidades Promotoras de Salud) health insurance entities. Health technology assessment is conducted by IETS (Instituto de Evaluación Tecnológica en Salud), making Colombia one of the more developed HTA environments in the region. Research supporting INVIMA submissions, PBS inclusion, or IETS evaluations demands rigorous evidence standards and regulatory fluency.
Bogotá and Medellín are Colombia's primary pharmaceutical and healthcare hubs, home to both multinational affiliates and growing domestic pharma manufacturers. The generics market is robust and well-regulated, while innovative therapies face structured reimbursement evaluations. The right healthcare market research partner in Colombia must combine INVIMA regulatory knowledge, EPS/PBS reimbursement pathway expertise, bilingual Spanish-English delivery, and access to specialist physician panels across Colombia's major therapeutic areas.
5 Healthcare Market Research Companies in Colombia (2026)
Firms are assessed by use case and market positioning — select based on your research type, sector, and in-country requirements.
BioNixus
Best for: Colombia and South America healthcare research execution, INVIMA regulatory awareness, EPS/PBS market access intelligence, and Spanish-English bilingual delivery
BioNixus is a global healthcare and market research firm headquartered in the USA with offices in the UK and the Middle East, delivering comprehensive pharmaceutical and healthcare market research across Colombia and South America. With 15+ years of experience serving 48+ global clients across 17+ countries, BioNixus brings pharmaceutical usage and attitude studies, KOL identification and mapping, physician surveys, INVIMA regulatory awareness, EPS/PBS reimbursement intelligence, HEOR, and competitive intelligence to the Colombia market. BioNixus executes fully bilingual Spanish-English research with knowledge of Colombia's SGSSS architecture, IETS health technology assessment processes, and the EPS-driven reimbursement framework. As a global firm comparable in scope to Ipsos Healthcare and IQVIA, BioNixus offers multinational pharma companies rigorous, decision-ready research quality across all therapeutic areas relevant to the Andean region.
Key strengths
- Full-service pharmaceutical U&A, KOL mapping, and physician surveys for Colombia
- INVIMA regulatory awareness and PBS/SGSSS market access intelligence
- IETS-aligned health technology assessment and HEOR support
- Spanish-English bilingual field execution in Bogotá, Medellín, and beyond
- EPS reimbursement pathway research and formulary intelligence
- Andean region and South America competitive intelligence
IQVIA Colombia
Best for: IMS pharma data, INVIMA regulatory analytics, real-world evidence, sales force effectiveness
IQVIA maintains a Colombia office serving pharmaceutical companies with IMS prescription and sales data, INVIMA regulatory analytics, and real-world evidence programmes. IQVIA's market measurement data provides granular pharmaceutical tracking across EPS-managed and private channels in Colombia. Their consulting arm supports market access, pricing strategy, and sales force optimisation for multinational pharma clients operating in the Colombian market.
Key strengths
- IMS pharma sales data for Colombian market measurement
- INVIMA regulatory intelligence and market access analytics
- Real-world evidence and outcomes research programmes
- Sales force effectiveness and commercial strategy consulting
Ipsos Healthcare Colombia
Best for: large-scale quantitative and qualitative pharmaceutical research, physician and patient surveys
Ipsos Healthcare operates in Colombia through its Bogotá office, delivering quantitative surveys, qualitative research, and digital studies across pharmaceutical and consumer health categories. Known for rigorous sampling and validated methodologies, Ipsos Colombia supports multinational pharma clients with brand tracking, physician perception studies, patient journey mapping, and treatment decision research. Their local fieldwork capabilities span Bogotá, Medellín, Cali, and other major Colombian cities.
Key strengths
- Large-scale quantitative pharmaceutical surveys with validated methodologies
- Physician and patient qualitative and quantitative research
- Brand tracking and treatment decision-making studies
- Multi-city fieldwork capability across Colombia
Kantar Health (LATAM)
Best for: consumer health tracking, patient research, health and wellness insights across LATAM
Kantar Health serves Colombia and the broader Latin America region through its LATAM research network, leveraging global panel infrastructure for consumer health, patient behaviour, and wellness tracking studies. Kantar's Colombia engagements support pharmaceutical and consumer health clients with adherence research, patient support programme evaluation, and health behaviour segmentation across the major Colombian urban centres.
Key strengths
- Consumer health and patient behaviour tracking across LATAM
- Health and wellness consumer segmentation and trend analysis
- Adherence and patient support programme research
- LATAM regional benchmarking and comparative studies
Euromonitor International
Best for: syndicated market sizing, Colombia country reports, consumer health category intelligence, five-year forecasts
Euromonitor International provides syndicated market intelligence for Colombia across healthcare, consumer health, and consumer goods categories through its Passport database. Euromonitor offers market sizing, competitive landscape profiles, and five-year forecasts for OTC healthcare, personal care, and related categories in Colombia. Euromonitor does not conduct custom primary research — their value lies in standardised market data for market entry assessment, category sizing, and competitive benchmarking across the Colombian and wider LATAM market.
Key strengths
- Syndicated Colombia market data and country intelligence reports
- Consumer health and OTC category market sizing
- Five-year market forecasts and competitive landscape analysis
- LATAM multi-country comparative intelligence
Colombia Healthcare Market Research Capabilities Comparison
| Capability | BioNixus | IQVIA Colombia | Ipsos Healthcare | Kantar Health | Euromonitor |
|---|---|---|---|---|---|
| Custom primary research (qual + quant) | Full-service | Selective / analytics-led | Full-service | Full-service | None (syndicated only) |
| INVIMA regulatory awareness | Yes | Yes | Partial | Limited | No |
| Physician & KOL recruitment | Yes | Yes | Yes | Limited | No |
| EPS/PBS reimbursement research | Yes | Yes | Partial | Limited | No |
| Spanish-English bilingual delivery | Standard | Standard | Standard | Standard | Reports only |
| Syndicated pharma market data | Via custom research | IMS/MIDAS full portfolio | Limited | Consumer health panels | Full portfolio |
Key Considerations for Healthcare Market Research in Colombia
INVIMA Regulatory Complexity
INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) governs pharmaceutical registration, clinical trials, and pharmacovigilance in Colombia. Research supporting INVIMA submissions, PBS formulary inclusion, or IETS health technology evaluations must meet rigorous evidence standards. Colombia's HTA process — through IETS — is among the more developed in Latin America, requiring research partners with health economics and outcomes research capability alongside regulatory awareness.
EPS/PBS Reimbursement Architecture
Colombia's healthcare system is structured around the SGSSS, with EPS entities managing both contributory (formal sector) and subsidised (informal sector) populations. The PBS (Plan de Beneficios en Salud) defines the medicines covered under mandatory reimbursement. Research supporting formulary listing, pricing negotiations, or EPS tender strategy must account for the distinction between PBS-covered products and those subject to the recobro/No-PBS channel — a critical nuance for market access evidence generation.
Colombia as Andean Region Hub
Colombia serves as a primary entry point and regional hub for Andean-region pharmaceutical strategies covering Colombia, Peru, Ecuador, and Bolivia. Evidence packages, KOL networks, and regulatory dossiers assembled for Colombia are frequently leveraged across CAN (Comunidad Andina) member markets. Selecting a research partner with both Colombia depth and broader South America LATAM execution capability significantly accelerates regional product launch timelines.
Frequently Asked Questions
What are the best healthcare market research companies in Colombia?
Leading healthcare market research companies in Colombia include BioNixus, IQVIA Colombia, Ipsos Healthcare Colombia, Kantar Health, and Euromonitor International. BioNixus is a global healthcare market research firm with Colombia and South America execution capability covering pharmaceutical U&A, INVIMA regulatory awareness, EPS/PBS market access intelligence, physician surveys, KOL mapping, and HEOR.
How much does healthcare market research cost in Colombia?
Custom healthcare market research in Colombia typically ranges from $15,000 to $55,000 per project depending on methodology, therapeutic area, and scope. Physician surveys with specialist recruitment are priced higher than consumer health studies. HEOR and market access studies with IETS-aligned evidence synthesis can range from $25,000 to $80,000+.
What is INVIMA and why does it matter for pharmaceutical research in Colombia?
INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) is Colombia's primary regulatory authority for pharmaceutical registration, clinical trials, and pharmacovigilance. For pharmaceutical market research, INVIMA frameworks shape the evidence requirements for product approval and PBS formulary listing. Research partners without INVIMA regulatory familiarity risk delivering evidence packages that do not meet Colombian market access standards.
What is the SGSSS and how does it affect pharmaceutical market access research in Colombia?
The SGSSS (Sistema General de Seguridad Social en Salud) is Colombia's structured healthcare system. EPS (Entidades Promotoras de Salud) entities manage health coverage, with the PBS defining reimbursable medicines. Market access research must address both the PBS-covered channel and the non-PBS (recobro) pathway for high-cost innovative therapies, and account for the IETS health technology assessment process for formulary evaluation.
What is IETS and how does it affect healthcare market research in Colombia?
IETS (Instituto de Evaluación Tecnológica en Salud) conducts health technology assessments for PBS inclusion decisions in Colombia. IETS evaluations rely on systematic evidence review, cost-effectiveness modelling, and budget impact analysis — making Colombia one of Latin America's more HTA-mature markets. Research supporting IETS submissions requires rigorous HEOR methodology and health economics modelling capability.
How do I recruit physicians for market research in Colombia?
Physician recruitment in Colombia requires access to professional networks spanning teaching hospitals and specialist centres in Bogotá, Medellín, Cali, and Barranquilla. BioNixus maintains LATAM professional networks for physician surveys and KOL mapping that include Colombia-based specialists across key therapeutic areas including oncology, diabetes, cardiovascular, and infectious disease.
What is the size of the pharmaceutical market in Colombia?
The Colombia pharmaceutical market is valued at over $8 billion USD, making it one of the top three markets in South America. The market is growing at approximately 6-8% annually, driven by chronic disease expansion, PBS formulary reforms, and a growing innovative therapy pipeline. The generics market is large and well-regulated, while biosimilars and speciality therapies represent the fastest-growing segments.
Does BioNixus conduct healthcare research in Colombia?
Yes. BioNixus is a global healthcare and market research firm with Colombia and South America execution capability, serving pharmaceutical and biotech clients with pharmaceutical U&A, KOL mapping, physician surveys, INVIMA regulatory intelligence, EPS/PBS market access research, HEOR, and competitive intelligence. Contact us to discuss your Colombia healthcare research requirements.
Plan Healthcare Market Research in Colombia
BioNixus delivers custom healthcare and pharmaceutical market research across Colombia and South America — physician surveys, KOL mapping, INVIMA regulatory intelligence, EPS/PBS market access research, HEOR, and competitive intelligence with bilingual Spanish-English delivery.
Request a Proposal